AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26179482
Drug: Tofogliflozin 20
RxNorm normalized name: sotagliflozin
DrugBank: Sotagliflozin (DB12713)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Tofogliflozin 20 mg
Trial: 31606880
Drug: Ipragliflozin 50
RxNorm normalized name: BEXAGLIFLOZIN
DrugBank: Bexagliflozin (DB12236)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipragliflozin 50 mg
Trial: 19760932
Drug: Antibiotic combination
RxNorm normalized name: combinations of different antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic combination therapy (amoxicillin, tetracycline, and metronidazole) for 2 weeks
Trial: 15813838
Drug: Antibiotic combination
RxNorm normalized name: combinations of different antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic combination therapy
Trial: 15220014
Drug: Tigecycline 25
RxNorm normalized name: Tigecycline
DrugBank: Tigecycline (DB00560)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tigecycline 25 mg IV q12h for 7 to 14 days
Trial: 15220014
Drug: Tigecycline 50
RxNorm normalized name: tigecycline 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tigecycline 50 mg IV q12h for 7 to 14 days
Trial: 9692587
Drug: bupivacaine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 1.5 mg/kg
Trial: 9692587
Drug: bupivacaine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 1.5 mg/kg with 1 in 200000 adrenaline
Trial: 23428340
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose filtered back projection (FBP) with 120 kVp
Trial: 23428340
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose filtered back projection (FBP) with 80 kVp
Trial: 19772452
Drug: 6 U‐eq
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 U‐eq plus two 2 U‐eq capsules (4.4 mg total)
Trial: 19772452
Drug: two 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: two 10 U‐eq capsules (7.8 mg total)
Trial: 9257203
Drug: Rocuronium bromide
RxNorm normalized name: Rocuronium Bromide
DrugBank: Rocuronium (DB00728)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rocuronium bromide 0.7 mg/kg
Trial: 9257203
Drug: Rocuronium bromide
RxNorm normalized name: Rocuronium Bromide
DrugBank: Rocuronium (DB00728)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rocuronium bromide 0.9 mg/kg
Trial: 26076938
Drug: Colchicine, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine, 1 mg daily (n=98)
Trial: 21768314
Drug: 2 full
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 full doses (0.5 mL) of trivalent inactivated influenza vaccine (TIV)
Trial: 21768314
Drug: 2 half
RxNorm normalized name: 1/2 Halfprin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 half doses (0.25 mL) of trivalent inactivated influenza vaccine (TIV)
Trial: 19649267
Drug: Comparator drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparator drugs (MAS3, artemether-lumefantrine, amodiaquine+sulfadoxine-pyrimethamine, artesunate+amodiaquine)
Trial: 18029950
Drug: Intrathecal drug
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal drug delivery systems (IDDSs)
Trial: 21526889
Drug: LRPT 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LRPT 40 mg co-administered with clopidogrel 75 mg
Trial: 21526889
Drug: LRPT 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LRPT 40 mg co-administered with aspirin 81 mg
Trial: 21526889
Drug: Clopidogrel 75
RxNorm normalized name: clopidogrel 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 75 mg alone
Trial: 10969672
Drug: Preoperative intraaortic
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative intraaortic balloon pump therapy
Trial: 9080162
Drug: Duraflo II
RxNorm normalized name: Duraflor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duraflo II heparin-coated circuits
Trial: 7504387
Drug: Ringer's acetate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer's acetate 2000 ml
Trial: 7504387
Drug: 20 ml.kg-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml.kg-1 LMW-HES (Mw 120,000)
Trial: 7504387
Drug: 20 ml.kg-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml.kg-1 HMW-HES (Mw 400,000)
Trial: 3531957
Drug: Argon laser
RxNorm normalized name: argon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argon laser photocoagulation treatment directed to the leakage site, using spot sizes of 200 mu in diameter, exposure times of 0.2 seconds, and low‐power intensities.
Trial: 29318424
Drug: Pasireotide 60
RxNorm normalized name: pasireotide 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 60 mg long-acting release
Trial: 21553161
Drug: Regadenoson (400-μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regadenoson (400-μg bolus injection)
Trial: 21553161
Drug: Adenosine (6-minute
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine (6-minute infusion)
Trial: 12743984
Drug: gemcitabine 1000
RxNorm normalized name: gemcitabine 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemcitabine 1000 mg/m2 and vinorelbine 20 mg/m2 on days 1, 8, and 15 of each 28-day cycle
Trial: 1356311
Drug: xamoterol 200
RxNorm normalized name: xamoterol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: xamoterol 200 mg two times a day
Trial: 1356311
Drug: verapamil 240
RxNorm normalized name: verapamil 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil 240 mg once a day
Trial: 2826563
Drug: Fiber (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fiber (15 g daily for 4 weeks)
Trial: 29122620
Drug: Convective RF
RxNorm normalized name: Aminosyn-RF 5.2 %, Sulfite-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Convective RF thermal therapy with Rezūm System
Trial: 28404067
Drug: Continuous wound
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous wound infiltration with bupivacaine plus patient-controlled analgesia with morphine
Trial: 16390890
Drug: DHEA (100-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA (100-400 mg/day)
Trial: 12728743
Drug: Once-daily administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily administration of quetiapine (400 or 600 mg)
Trial: 12728743
Drug: Twice-daily administration
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily administration of quetiapine (400 or 600 mg)
Trial: 12728743
Drug: Once-daily administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily administration of quetiapine
Trial: 12728743
Drug: Twice-daily administration
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily administration of quetiapine
Trial: 9890410
Drug: Pure oxygen
RxNorm normalized name: Pure oxygen
DrugBank: Oxygen (DB09140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pure oxygen administration for 30 min
Trial: 9890410
Drug: Pure oxygen
RxNorm normalized name: Pure oxygen
DrugBank: Oxygen (DB09140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pure oxygen administration for 30 min with right atrial pacing in 12 patients
Trial: 2076623
Drug: Naproxen gel
RxNorm normalized name: Naproxen
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen gel (10%)
Trial: 2076623
Drug: Flufenamic acid
RxNorm normalized name: Flufenamic acid
DrugBank: Flufenamic acid (DB02266)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flufenamic acid gel (3%)
Trial: 20146365
Drug: Inhaled tobramycin
RxNorm normalized name: tobramycin Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled tobramycin
Trial: 18326958
Drug: Amlodipine/valsartan 10/160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine/valsartan 10/160 mg
Trial: 20236700
Drug: Valsartan 160
RxNorm normalized name: valsartan 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 160 mg
Trial: 16723303
Drug: HT50 (0.050
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HT50 (0.050 mg/day)
Trial: 16723303
Drug: HT25 (0.025
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HT25 (0.025 mg/day)
Trial: 15523323
Drug: High-dose enalapril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose enalapril
Trial: 9024100
Drug: Micronized estradiol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized estradiol, 0.5 mg
Trial: 8328566
Drug: Sustained-release alprazolam
RxNorm normalized name: alprazolam Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release alprazolam (highest mean dose = 4.7 mg/day)
Trial: 23530786
Drug: Propofol 1
RxNorm normalized name: propofol 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1 mg/kg alone (Group P)
Trial: 23530786
Drug: Propofol 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 0.5 mg/kg and remifentanil 1 µg/kg (Group R)
Trial: 20610555
Drug: Morphine 100
RxNorm normalized name: MORPHINE 100MG/NALTREXONE 4MG SA CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 100 microg/kg
Trial: 20610555
Drug: Morphine 50
RxNorm normalized name: MORPHINE 50MG/NALTREXONE 2MG SA CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 50 microg/kg
Trial: 12720620
Drug: Oral supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral supplementation (200 ml sweet or salty sip feed twice daily, providing 500 kcal, 21 g protein per day)
Trial: 12720620
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no oral supplementation)
Trial: 9110065
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir (500 mg six times a day)
Trial: 9110065
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir (1000 mg three times a day)
Trial: 9110065
Drug: Intravenous ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ganciclovir (5 mg/kg per day)
Trial: 12491207
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir
Trial: 1901199
Drug: Rifater (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifater (combined formulation of isoniazid, rifampin, and pyrazinamide)
Trial: 1901199
Drug: Separate drugs
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate drugs (isoniazid, rifampin, and pyrazinamide administered separately)
Trial: 19946241
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no statin therapy)
Trial: 23805813
Drug: Scaling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling and root planing plus oral hygiene instruction
Trial: 20473066
Drug: Desvenlafaxine 50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desvenlafaxine 50, 100, 200, or 400 mg/d
Trial: 11885569
Drug: Acute tryptophan
RxNorm normalized name: Tryptophan
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acute tryptophan (TRP) depletion (100 g of an amino acid mixture without TRP)
Trial: 2501032
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin patch (3.3 cm2)
Trial: 2501032
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin patch (6.7 cm2)
Trial: 2501032
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin patch (13.3 cm2)
Trial: 28832429
Drug: Both HT
RxNorm normalized name: 5-HT
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both HT formulations (o-CEE and t-E2)
Trial: 27555179
Drug: Intranasal dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal dexmedetomidine (DEX) 1 μg/kg
Trial: 30562785
Drug: Intranasal dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal dexmedetomidine (DEX) 2 μg/kg
Trial: 24286456
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg of GW766994 twice daily for 10 days followed by prednisone 30 mg for 5 days
Trial: 15992231
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (weekly meetings only)
Trial: 11514924
Drug: Other therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other therapy
Trial: 9422018
Drug: Oral metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral metronidazole (400 mg) twice daily for two days at 24 weeks of gestation
Trial: 8181027
Drug: Nitrate therapy
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate therapy without hydralazine
Trial: 8181027
Drug: Nitrates in
RxNorm normalized name: organic nitrates in combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrates in patients treated with ACE inhibitors
Trial: 27602705
Drug: Text Messaging
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Text Messaging (TM) intervention with 2-way reminders about medication administration.
Trial: 26397085
Drug: Supervised spinal
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised spinal stabilization exercises (weekly physical therapy for 8 weeks)
Trial: 26397085
Drug: 1-time treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-time treatment followed by home exercises (unsupervised group)
Trial: 24653520
Drug: Intravenous paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous paracetamol (15 mg/kg)
Trial: 23503913
Drug: Intravenous dipyrone
RxNorm normalized name: dipyrone
DrugBank: Metamizole (DB04817)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dipyrone (15 mg/kg)
Trial: 23503913
Drug: Intravenous paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous paracetamol and dipyrone
Trial: 18834691
Drug: Traditional oral
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional oral hygiene instruction for 20 min.
Trial: 9632123
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg acarbose with 100 g sucrose
Trial: 9632123
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with 100 g sucrose
Trial: 3205904
Drug: Intravenous oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous oxytocin (OT) infusion
Trial: 26306883
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) in addition to traditional physical therapy, administered three times per week for three months.
Trial: 26306883
Drug: Pulsed electromagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed electromagnetic field (PEMF) in addition to traditional physical therapy, administered three times per week for three months.
Trial: 18444531
Drug: Patient Controlled
RxNorm normalized name: PATIENT CONTROLLED ANALGESIA VIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient Controlled Epidural Analgesia (Bupivacaine 0.08% + 3 microg/ml of Fentanyl, 6 ml/h and bolus of 5 ml)
Trial: 16165104
Drug: LI160 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LI160 (2 x 750 mg)
Trial: 8772586
Drug: Physiological dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological dose of GH (0.04 U/kg)
Trial: 8772586
Drug: Supraphysiological dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supraphysiological dose of GH (0.08 U/kg)
Trial: 6503959
Drug: Pre- and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre- and postoperative radiotherapy (total dose 5000 rads, with 3000 rads preoperative) and adjuvant chemotherapy (FT-207, 600mg/day for over 3 months) in group A.
Trial: 30282392
Drug: 0.9% normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% normal saline solution (placebo)
Trial: 24813670
Drug: Classroom-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Classroom-based cognitive behaviour therapy (CBT)
Trial: 21047406
Drug: Oral beta-blockers
RxNorm normalized name: beta carotene Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral beta-blockers at admission
Trial: 21047406
Drug: Oral beta-blockers
RxNorm normalized name: beta carotene Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral beta-blockers before hospital discharge
Trial: 12133040
Drug: eletriptan 40
RxNorm normalized name: eletriptan 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eletriptan 40 mg
Trial: 12133040
Drug: eletriptan 20
RxNorm normalized name: eletriptan 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eletriptan 20 mg
Trial: 10088733
Drug: Ketorolac tromethamine
RxNorm normalized name: Ketorolac Tromethamine
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac tromethamine 0.5% ophthalmic solution (Acular) administered four times daily for 14 days
Trial: 16792136
Drug: Intermittent oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent oral alfacalcidol (2 microg after each dialysis session)
Trial: 16792136
Drug: Continuous oral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous oral alfacalcidol (1 microg given 6 days/week)
Trial: 27414159
Drug: Sildenafil (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (100 mg)
Trial: 3046537
Drug: Oral theophylline
RxNorm normalized name: theophylline Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral theophylline
Trial: 1729064
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of theophylline and salbutamol
Trial: 30655255
Drug: Custom administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Custom administration of a standard dose of gadobutrol
Trial: 17572643
Drug: Scheduled acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scheduled acetaminophen (665 mg modified-release tablets, three times a day for five days)
Trial: 17572643
Drug: As needed
RxNorm normalized name: diphenhydramine
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: As needed acetaminophen (665 mg tablets as needed)
Trial: 17572643
Drug: As needed
RxNorm normalized name: diphenhydramine
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: As needed acetaminophen
Trial: 8722438
Drug: Captopril (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50 mg twice a day orally for 12 months)
Trial: 6414571
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus dipyridamole (ASA/DPM)
Trial: 22237003
Drug: Valganciclovir prophylaxis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valganciclovir prophylaxis for 200 days (900 mg once daily)
Trial: 19931952
Drug: Influenza vaccine
RxNorm normalized name: Influenza vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccine (2007 southern hemisphere influenza vaccine); coverage among ACF residents ranged from 59% to 100%.
Trial: 17462091
Drug: Usual Care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual Care Plus Musculoskeletal Physiotherapy Treatment (UCMT)
Trial: 9733427
Drug: Distraction treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distraction treatment (20 sessions)
Trial: 9733427
Drug: Focusing treatment
RxNorm normalized name: ficusin
DrugBank: Psoralen (DB18665)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focusing treatment (20 sessions)
Trial: 8555030
Drug: Pyridoxine hydrochloride
RxNorm normalized name: Pyridoxine Hydrochloride
DrugBank: Pyridoxine phosphate (DB02209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pyridoxine hydrochloride 50 mg once daily for 4 weeks
Trial: 6781321
Drug: Oral diltiazem
RxNorm normalized name: diltiazem Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diltiazem 90 mg
Trial: 6781321
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin 0.3 mg
Trial: 28029390
Drug: Olumacostat glasaretil
RxNorm normalized name: Olumacostat glasaretil
DrugBank: Olumacostat glasaretil (DB12642)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olumacostat glasaretil (OG) 7.5% gel
Trial: 25017924
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral hormone therapy
Trial: 25017924
Drug: Non-oral hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-oral hormone therapy